BLOOD PLASMA DERIVATIVES MARKET ANALYSIS
Global Blood Plasma Derivatives Market: Key Developments
In October 2022, Grifols SA inaugurated a new albumin purification and filling plant at its global manufacturing and supply hub in Dublin, Ireland.
In September 2022, CSL Behring K.K. received manufacturing and marketing approval from the Ministry of Health, Labour and Welfare of Japan for Berinert S.C. Injection 2000, a lyophilized human C1-esterase inhibitor concentrate for subcutaneous (SC) injection in plasma derivative, for the prevention of acute hereditary angioedema (HAE) attack.
In March 2021, Grifols S.A. acquired 25 U.S.-based plasma centres from BPL ensuring one Billion additional litters for fractionation to improve people's lives.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
